Parkinson's Disease, adaptive DBS and FDA

FDA Approves Adaptive Deep Brain Stimulator for Parkinson's Disease
The FDA approved adaptive deep brain stimulation (DBS) technology (BrainSense adaptive DBS and BrainSense electrode identifier) for people with Parkinson's disease, Medtronic announced Monday. Like other DBS devices,
US FDA approves Medtronic's medical device for Parkinson's disease
The U.S. Food and Drug Administration has approved Medtronic's deep brain stimulation system for use in patients with Parkinson's disease, the medical device maker said on Monday.
FDA OKs First Adaptive DBS System for Parkinson’s Disease
The closed-loop system dynamically self-adjusts DBS therapy to individual brain activity in real time, providing personalized neuromodulation that responds to the patient’s changing needs.
Medtronic Parkinson's Disease Brain Stimulation System Gets FDA Approval
Medtronic said the Food and Drug Administration approved a brain stimulation system for people afflicted with Parkinson's disease.
Medtronic gains FDA OK for self-adjusting DBS system for Parkinson’s
The BrainSense Adaptive technology is an enhancement to Medtronic’s Percept DBS neurostimulators. The advancement personalizes therapy based on a patient’s brain activity in real-time. Therapy automatically adjusts, which minimizes the need for patients to manually change the level of stimulation to control symptoms.
FDA approves Medtronic’s adaptive technology for Parkinson’s
The company's adaptive deep brain stimulation technology for Parkinson's disease therapy is expected to be available nationwide in the next few months.
FDA Approves Medtronic’s BrainSense Adaptive Deep Brain Stimulation for Parkinson Disease
The BrainSense adaptive deep brain stimulation system personalizes therapy by dynamically adjusting stimulation based on real-time brain activity to improve Parkinson disease symptom control without manual adjustments.
In Parkinson’s fight, Medtronic’s first-in-the-world adaptive therapy feature wins FDA approval
After decades of development and trials, Medtronic has secured U.S. Food and Drug Administration approval for adaptive technology personalizing treatment of Parkinson’s symptoms using advanced stimulation deep in the brain.
Medtronic's deep brain stimulation system for Parkinson's disease wins FDA nod
Medtronic's FDA-approved BrainSense Adaptive DBS system revolutionizes Parkinson's therapy with real-time adjustments for personalized symptom control.
Parkinson’s Patients Have a New Way to Manage Their Symptoms
T here is still no cure for Parkinson’s disease, but the U.S. Food and Drug Administration (FDA) approved a new deep brain ...
Studies of Parkinson’s disease have long overlooked Pacific populations – our work shows why that must change
New research shows people in specific Polynesian communities have a much higher rate of a form of Parkinson’s disease ...
Indoor cycling event raises money to help those battling Parkinson's disease
"It does not take intelligence to throw money around and buy a company or buy a politician," Seth Abramson writes The post ...
Parkinson's centre a one-stop-shop of support for those with the neurological disease
Parkinson Wellness Projects’ 5,000-square-foot centre at Blanshard and Hillside offers everything from exercise programs to ...
TheHealthSite.com on MSN2d
Jerry Butler, Legendary Soul Singer 'The Iceman,' Dies at 85 After Long Battle With Parkinson's Disease
Legendary soul singer Jerry Butler, known as "The Iceman," has passed away at 85, leaving behind an unforgettable legacy in ...
The Spun on MSN9h
Former NFL Quarterback Dead From Parkinson's at 74
A former NFL quarterback has passed away at 74 years old, following a battle with Parkinson's disease and prostate cancer.
manilatimes20h
Piding Pidi enables artist with Parkinson's Disease in NCCA Gallery Exhibit
SHOWCASING a 20-year collection of art, Elmer Nocheseda unveiled his lifelong works at the National Commission for Culture ...
Knowridge1d
Cholesterol may play a key role in Parkinson’s disease
Scientists in China have discovered a cholesterol-related compound that may contribute to the development of Parkinson’s disease. This compound, called 24-OHC, appears to help spread harmful protein ...